Is MOTS-c legal in New Hampshire?
status · caveats apply
Investigational mitochondrial-derived peptide; no FDA approval; PCAC vote on 503A bulks scheduled July 23, 2026; WADA S2 class-based capture. No state-level peptide restrictions beyond federal law in New Hampshire.
category: investigational · last verified May 13, 2026
§ 01
Quick answer
Investigational mitochondrial-derived peptide; no FDA approval; PCAC vote on 503A bulks scheduled July 23, 2026; WADA S2 class-based capture. No state-level peptide restrictions beyond federal law in New Hampshire.
§ 02
Full status breakdown
Federal status
FDA approval
investigational
DEA scheduling
not scheduled
503A compounding
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Same posture as other unapproved peptides — RUO label is not a safe harbor.
Personal possession: Not federally scheduled; possession is not a federal crime.
New Hampshire — state-specific
Sport-body status
WADA 2026
on prohibited list · class S2 · both
Captured by S2 class language and S0 (non-approved). Not specifically named.
USADA
banned
NCAA
banned
What we couldn’t verify
§ 03
Also known as
MOTS-c is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):
Mitochondrial Open Reading Frame 12S rRNA-cMOTS-c acetateCB4211 analogue
§ 04
Disclaimer
§ 05
Related
- Back to peptide legality lookup — pick a different compound or state
- MOTS-c research guide — mechanism, dosing math, vendor audits, COA data
- Peptide pricing index — what each compound costs per mg across audited vendors
- Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?
the roundup · monthly
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.
14,200 subscribers· 0 sponsored items· 11 issues since launch